Pfizer Inc.
PFE
23.52
USD+0.52
(+2.26%)Day's range
23.155
23.7
52 wk Range
20.92
31.54
Key ratios
Statements Highlights
| Period Ending | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
|---|---|---|---|---|---|---|
| Total Revenue | 41,908,000,000 | 81,288,000,000 | 100,330,000,000 | 58,496,000,000 | 63,627,000,000 | |
| Gross Profit | 33,216,000,000 | 50,467,000,000 | 65,986,000,000 | 28,809,000,000 | 47,207,000,000 | |
| Operating Income | 10,630,000,000 | 24,833,000,000 | 40,030,000,000 | 3,359,000,000 | 14,938,000,000 | |
| Net Income | 7,020,000,000 | 21,979,000,000 | 31,372,000,000 | 2,119,000,000 | 8,031,000,000 | |
| Total Assets | 154,229,000,000 | 181,477,000,000 | 197,206,000,000 | 226,501,000,000 | 213,396,000,000 | |
| Total Current Liabilities | 25,920,000,000 | 42,671,000,000 | 42,138,000,000 | 47,794,000,000 | 42,995,000,000 | |
| Total Equity | 63,473,000,000 | 77,463,000,000 | 95,917,000,000 | 89,288,000,000 | 88,497,000,000 | |
| Free Cash Flow | 11,612,000,000 | 29,869,000,000 | 26,031,000,000 | 4,793,000,000 | 9,835,000,000 | |
| Cash from Operations | 14,403,000,000 | 32,580,000,000 | 29,267,000,000 | 8,700,000,000 | 12,744,000,000 | |
| Cash from Investing | -4,271,000,000 | -22,546,000,000 | -15,783,000,000 | -32,278,000,000 | 2,652,000,000 | |
| Cash from Financing | -9,649,000,000 | -9,816,000,000 | -14,834,000,000 | 26,066,000,000 | -17,140,000,000 | |
| Net Change in Cash | 475,000,000 | 158,000,000 | -1,515,000,000 | 2,449,000,000 | -1,810,000,000 |